Literature DB >> 24899185

Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.

Neeltje van Doremalen1, Kerri L Miazgowicz1, Shauna Milne-Price1, Trenton Bushmaker1, Shelly Robertson1, Dana Scott2, Joerg Kinne3, Jason S McLellan4, Jiang Zhu5, Vincent J Munster6.   

Abstract

UNLABELLED: Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012. Recently, the MERS-CoV receptor dipeptidyl peptidase 4 (DPP4) was identified and the specific interaction of the receptor-binding domain (RBD) of MERS-CoV spike protein and DPP4 was determined by crystallography. Animal studies identified rhesus macaques but not hamsters, ferrets, or mice to be susceptible for MERS-CoV. Here, we investigated the role of DPP4 in this observed species tropism. Cell lines of human and nonhuman primate origin were permissive of MERS-CoV, whereas hamster, ferret, or mouse cell lines were not, despite the presence of DPP4. Expression of human DPP4 in nonsusceptible BHK and ferret cells enabled MERS-CoV replication, whereas expression of hamster or ferret DPP4 did not. Modeling the binding energies of MERS-CoV spike protein RBD to DPP4 of human (susceptible) or hamster (nonsusceptible) identified five amino acid residues involved in the DPP4-RBD interaction. Expression of hamster DPP4 containing the five human DPP4 amino acids rendered BHK cells susceptible to MERS-CoV, whereas expression of human DPP4 containing the five hamster DPP4 amino acids did not. Using the same approach, the potential of MERS-CoV to utilize the DPP4s of common Middle Eastern livestock was investigated. Modeling of the DPP4 and MERS-CoV RBD interaction predicted the ability of MERS-CoV to bind the DPP4s of camel, goat, cow, and sheep. Expression of the DPP4s of these species on BHK cells supported MERS-CoV replication. This suggests, together with the abundant DPP4 presence in the respiratory tract, that these species might be able to function as a MERS-CoV intermediate reservoir. IMPORTANCE: The ongoing outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) has caused 701 laboratory-confirmed cases to date, with 249 fatalities. Although bats and dromedary camels have been identified as potential MERS-CoV hosts, the virus has so far not been isolated from any species other than humans. The inability of MERS-CoV to infect commonly used animal models, such as hamster, mice, and ferrets, indicates the presence of a species barrier. We show that the MERS-CoV receptor DPP4 plays a pivotal role in the observed species tropism of MERS-CoV and subsequently identified the amino acids in DPP4 responsible for this restriction. Using a combined modeling and experimental approach, we predict that, based on the ability of MERS-CoV to utilize the DPP4 of common Middle East livestock species, such as camels, goats, sheep, and cows, these form a potential MERS-CoV intermediate host reservoir species.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899185      PMCID: PMC4136254          DOI: 10.1128/JVI.00676-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling.

Authors:  Donald Petrey; Zhexin Xiang; Christopher L Tang; Lei Xie; Marina Gimpelev; Therese Mitros; Cinque S Soto; Sharon Goldsmith-Fischman; Andrew Kernytsky; Avner Schlessinger; Ingrid Y Y Koh; Emil Alexov; Barry Honig
Journal:  Proteins       Date:  2003

3.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

4.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

Review 5.  Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

Authors:  Anne-Marie Lambeir; Christine Durinx; Simon Scharpé; Ingrid De Meester
Journal:  Crit Rev Clin Lab Sci       Date:  2003-06       Impact factor: 6.250

6.  Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.

Authors:  Marcel A Müller; V Stalin Raj; Doreen Muth; Benjamin Meyer; Stephan Kallies; Saskia L Smits; Robert Wollny; Theo M Bestebroer; Sabine Specht; Tasnim Suliman; Katrin Zimmermann; Tabea Binger; Isabella Eckerle; Marco Tschapka; Ali M Zaki; Albert D M E Osterhaus; Ron A M Fouchier; Bart L Haagmans; Christian Drosten
Journal:  mBio       Date:  2012-12-11       Impact factor: 7.867

7.  Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia.

Authors:  Thomas Briese; Nischay Mishra; Komal Jain; Iyad S Zalmout; Omar J Jabado; William B Karesh; Peter Daszak; Osama B Mohammed; Abdulaziz N Alagaili; W Ian Lipkin
Journal:  MBio       Date:  2014-04-29       Impact factor: 7.867

8.  Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential.

Authors:  Eveline Kindler; Hulda R Jónsdóttir; Doreen Muth; Ole J Hamming; Rune Hartmann; Regulo Rodriguez; Robert Geffers; Ron A M Fouchier; Christian Drosten; Marcel A Müller; Ronald Dijkman; Volker Thiel
Journal:  MBio       Date:  2013-02-19       Impact factor: 7.867

9.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

Authors:  V Stalin Raj; Huihui Mou; Saskia L Smits; Dick H W Dekkers; Marcel A Müller; Ronald Dijkman; Doreen Muth; Jeroen A A Demmers; Ali Zaki; Ron A M Fouchier; Volker Thiel; Christian Drosten; Peter J M Rottier; Albert D M E Osterhaus; Berend Jan Bosch; Bart L Haagmans
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

10.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

View more
  123 in total

1.  Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.

Authors:  Kun Li; Christine L Wohlford-Lenane; Rudragouda Channappanavar; Jung-Eun Park; James T Earnest; Thomas B Bair; Amber M Bates; Kim A Brogden; Heather A Flaherty; Tom Gallagher; David K Meyerholz; Stanley Perlman; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

2.  Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.

Authors:  Anurodh Shankar Agrawal; Tania Garron; Xinrong Tao; Bi-Hung Peng; Maki Wakamiya; Teh-Sheng Chan; Robert B Couch; Chien-Te K Tseng
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus.

Authors:  Che-Man Chan; Hin Chu; Yixin Wang; Bosco Ho-Yin Wong; Xiaoyu Zhao; Jie Zhou; Dong Yang; Sze Pui Leung; Jasper Fuk-Woo Chan; Man-Lung Yeung; Jinghua Yan; Guangwen Lu; George Fu Gao; Kwok-Yung Yuen
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

4.  CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.

Authors:  Christopher M Coleman; Jeanne M Sisk; Gabor Halasz; Jixin Zhong; Sarah E Beck; Krystal L Matthews; Thiagarajan Venkataraman; Sanjay Rajagopalan; Christos A Kyratsous; Matthew B Frieman
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 5.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

6.  Computational and Functional Analysis of the Virus-Receptor Interface Reveals Host Range Trade-Offs in New World Arenaviruses.

Authors:  Scott A Kerr; Eleisha L Jackson; Oana I Lungu; Austin G Meyer; Ann Demogines; Andrew D Ellington; George Georgiou; Claus O Wilke; Sara L Sawyer
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

Review 7.  Receptor recognition mechanisms of coronaviruses: a decade of structural studies.

Authors:  Fang Li
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

8.  Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.

Authors:  Kayla M Peck; Trevor Scobey; Jesica Swanstrom; Kara L Jensen; Christina L Burch; Ralph S Baric; Mark T Heise
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 9.  MERS-CoV spike protein: a key target for antivirals.

Authors:  Lanying Du; Yang Yang; Yusen Zhou; Lu Lu; Fang Li; Shibo Jiang
Journal:  Expert Opin Ther Targets       Date:  2016-12-21       Impact factor: 6.902

10.  Mapping the Specific Amino Acid Residues That Make Hamster DPP4 Functional as a Receptor for Middle East Respiratory Syndrome Coronavirus.

Authors:  Neeltje van Doremalen; Kerri L Miazgowicz; Vincent J Munster
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.